The results were consistent with the log-rank test, showing a significant association between CILP2 expression and prognosis in ACC, KIRC, and pancreatic adenocarcinoma (PAAD) (Figure 2C). This evidence concerns the gene CILP2 and pancreatic adenocarcinoma.